Pentavalent Antimonials, also called pentavalent antimony compounds, are used to treat patients with leishmaniasis, but they have collateral effects and, in some cases, low cure rate. The compounds currently available for clinical use are: sodium stibogluconate and meglumine antimoniate. Pentavalent antimonials can only be given by injection.
This report contains market size and forecasts of Pentavalent Antimonials in global, including the following market information:
Global Pentavalent Antimonials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pentavalent Antimonials Market Sales, 2017-2022, 2023-2028, (g)
Global top five Pentavalent Antimonials companies in 2021 (%)
The global Pentavalent Antimonials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sodium Stibogluconate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pentavalent Antimonials include Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David and Science Direct, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pentavalent Antimonials manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pentavalent Antimonials Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Pentavalent Antimonials Market Segment Percentages, by Type, 2021 (%)
Sodium Stibogluconate
Meglumine Antimoniate
Global Pentavalent Antimonials Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Pentavalent Antimonials Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Global Pentavalent Antimonials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Pentavalent Antimonials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pentavalent Antimonials revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pentavalent Antimonials revenues share in global market, 2021 (%)
Key companies Pentavalent Antimonials sales in global market, 2017-2022 (Estimated), (g)
Key companies Pentavalent Antimonials sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct